- Home
- DSGN vs API Comparison
DSGN vs API Comparison
Compare DSGN & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- API
- Stock Information
- Founded
- DSGN 2017
- API 2013
- Country
- DSGN United States
- API United States
- Employees
- DSGN N/A
- API 790
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- API Computer Software: Prepackaged Software
- Sector
- DSGN Health Care
- API Technology
- Exchange
- DSGN Nasdaq
- API Nasdaq
- Market Cap
- DSGN 264.4M
- API 419.4M
- IPO Year
- DSGN 2021
- API 2020
- Fundamental
- Price
- DSGN $5.57
- API $4.56
- Analyst Decision
- DSGN Hold
- API
- Analyst Count
- DSGN 3
- API 0
- Target Price
- DSGN $7.00
- API N/A
- AVG Volume (30 Days)
- DSGN 142.1K
- API 1.5M
- Earning Date
- DSGN 11-07-2024
- API 11-25-2024
- Dividend Yield
- DSGN N/A
- API N/A
- EPS Growth
- DSGN N/A
- API N/A
- EPS
- DSGN N/A
- API N/A
- Revenue
- DSGN N/A
- API $138,287,000.00
- Revenue This Year
- DSGN N/A
- API N/A
- Revenue Next Year
- DSGN N/A
- API $8.09
- P/E Ratio
- DSGN N/A
- API N/A
- Revenue Growth
- DSGN N/A
- API N/A
- 52 Week Low
- DSGN $2.13
- API $1.65
- 52 Week High
- DSGN $7.77
- API $6.43
- Technical
- Relative Strength Index (RSI)
- DSGN 47.80
- API 61.82
- Support Level
- DSGN $5.32
- API $3.97
- Resistance Level
- DSGN $7.77
- API $4.74
- Average True Range (ATR)
- DSGN 0.58
- API 0.62
- MACD
- DSGN -0.09
- API 0.04
- Stochastic Oscillator
- DSGN 19.12
- API 66.91
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.